Treatment Options for HIV-Associated Tuberculosis

Onyebujoh, Philip Chukwuka; Ribeiro, Isabela; Whalen, Christopher Curtis
August 2007
Journal of Infectious Diseases;8/15/2007 Supplement, Vol. 196, pS35
Academic Journal
The vicious interaction between the human immunodeficiency virus (HIV) infection and tuberculosis (TB) pandemics poses special challenges to national control programs and individual physicians. Although recommendations for the treatment of TB in HIV-infected patients do not significantly differ from those for HIV-uninfected patients, the appropriate management of HIV-associated TB is complicated by health system issues, diagnostic difficulties, adherence concerns, overlapping adverse-effect profiles and drug interactions, and the occurrence of paradoxical reactions after the initiation of effective antiretroviral therapy. In this article, recommended treatment strategies and novel approaches to the management of HIV-associated TB are reviewed, including adjuvant treatment and options for treatment simplification. A focused research agenda is proposed in the context of the limitations of the current knowledge framework.


Related Articles

  • HIV Infection: The Role of Primary Care. ROMANELLI, FRANK; MATHENY, SAMUEL C. // American Family Physician;11/1/2009, Vol. 80 Issue 9, p946 

    Human immunodeficiency virus infection was first documented in the United States in 1981. Since that time, significant strides have been made in the prevention and treatment of the condition. Screening is paramount in identifying early infection and is now a routine component of primary care....

  • Where to Start?  // Guide;May2006, Vol. 26 Issue 5, p77 

    The article states that the use of antiretroviral therapy for HIV patients still faces challenges, such as major adverse effects, difficulties of patients to comply with treatment regimen, and antiretroviral drug resistance. Patients are encouraged to visit www.hivinsite.org to obtain...

  • Improving Coping Skills for Self-management of Treatment Side Effects Can Reduce Antiretroviral Medication Nonadherence among People Living with HIV. Johnson, Mallory O.; Dilworth, Samantha E.; Taylor, Jonelle M.; Neilands, Torsten B. // Annals of Behavioral Medicine;Feb2011, Vol. 41 Issue 1, p83 

    Background: Human immunodeficiency virus (HIV) treatment side effects have a deleterious impact on treatment adherence, which is necessary to optimize treatment outcomes including morbidity and mortality. Purpose: To examine the effect of the Balance Project intervention, a five-session,...

  • Global patient safety and antiretroviral drug–drug interactions in the resource-limited setting. Seden, Kay; Khoo, Saye H.; Back, David; Byakika-Kibwika, Pauline; Lamorde, Mohammed; Ryan, Mairin; Merry, Concepta // Journal of Antimicrobial Chemotherapy (JAC);Jan2013, Vol. 68 Issue 1, p1 

    Scale-up of HIV treatment services may have contributed to an increase in functional health facilities available in resource-limited settings and an increase in patient use of facilities and retention in care. As more patients are reached with medicines, monitoring patient safety is increasingly...

  • Treatment for Adult HIV Infection: 2004 Recommendations of the International AIDS Society-USA Panel. Yeni, Patrick G.; Hammer, Scott M.; Hirsch, Martin S.; Saag, Michael S.; Schechter, Mauro; Carpenter, Charles C. J.; Fischl, Margaret A.; Gatell, Jose M.; Gazzard, Brian G.; Jacobsen, Donna M.; Katzenstein, David A.; Montaner, Julio S. G.; Richman, Douglas D.; Schooley, Robert T.; Thompson, Melanie A.; Vella, Stefano; Volberding, Paul A. // JAMA: Journal of the American Medical Association;7/14/2004, Vol. 292 Issue 2, p251 

    Context Substantial changes in the field of human immunodeficiency virus (HIV) treatment have occurred in the last 2 years, prompting revision of the guidelines for antiretroviral management of adults with established HIV infection. Objective To update recommendations for physicians who provide...

  • Medikamenteninteraktion bei HIV-Therapien. Mossdorf, E.; Marzolini, C.; Fasel, D.; Fayet, A. Mello; Blum, C.; Donath, M.; Battegay, M. // Praxis (16618157);9/21/2011, Vol. 100 Issue 19, p1193 

    We develop a differential diagnosis and diagnostic approach to a possible drug-drug interaction between a cART based on boosted atazanavir and newly given drugs. History taking should not only encompass prescribed but also over-the-counter medication. Exchange of information between attending...

  • Pharmacists as providers of HIV pre-exposure prophylaxis. Bruno, Christine; Saberi, Parya // International Journal of Clinical Pharmacy;Dec2012, Vol. 34 Issue 6, p803 

    The efficacy of HIV pre-exposure prophylaxis (PrEP) has been demonstrated in four clinical trials to date; however, the success of PrEP is largely dependent on high levels of medication adherence. Due to their extensive experience and expertise in medication adherence counseling, as well as...

  • Estrategias farmacológicas para facilitar la adherencia a la terapia antirretroviral altamente activa. Clapé-Laffita, Oneyda // Revista Medica del IMSS;2013, Vol. 51 Issue 2, p200 

    Background: adherence to antiretroviral therapy is an important factor in achieving human immunodeficiency virus suppression. The aim was to apply a pharmacological strategy, based in pharmacokinetics measures for improving the adherence to antiretroviral therapy. Methods: We did a descriptive...

  • Nonadherence to Antiretroviral Therapy in HIV-Positive Patients in Costa Rica. Stout, Brian Douglas; Leon, Maria Paz; Niccolai, Linda M. // AIDS Patient Care & STDs;May2004, Vol. 18 Issue 5, p297 

    A cross-sectional study was performed among seropositive individuals who sought HIV treatment at an outpatient clinic in San Jose, Costa Rica, to determine the prevalence, predictors, and reasons for nonadherence to antiretroviral. A structured, face-to-face interview was administered to 88...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics